Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Investor Relations

Stock Quote

NASDAQCRDF
$2.79
NASDAQCRDF
Open
$3.01
Change
-$0.23 (-7.62%)
Day's Range
$2.75 - $3.09
52-Week Range
$1.13 - $8.58
Volume
447.5K
Market Cap
$120.9M